Log in

Vermillion Stock Forecast, Price & News

-0.17 (-5.22 %)
(As of 09/30/2020 12:00 AM ET)
Today's Range
Now: $3.09
50-Day Range
MA: $3.01
52-Week Range
Now: $3.09
Volume642,778 shs
Average Volume440,144 shs
Market Capitalization$300.41 million
P/E RatioN/A
Dividend YieldN/A
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.
Read More
Vermillion logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostic substances
Current SymbolNASDAQ:VRML



Sales & Book Value

Annual Sales$4.54 million
Book Value$0.09 per share


Net Income$-15,240,000.00
Net Margins-307.31%


Market Cap$300.41 million
Next Earnings DateN/A
-0.17 (-5.22 %)
(As of 09/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VRML News and Ratings via Email

Sign-up to receive the latest news and ratings for VRML and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Vermillion (NASDAQ:VRML) Frequently Asked Questions

How has Vermillion's stock been impacted by Coronavirus?

Vermillion's stock was trading at $0.84 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, VRML stock has increased by 267.3% and is now trading at $3.0850.
View which stocks have been most impacted by COVID-19

How were Vermillion's earnings last quarter?

Vermillion, Inc. (NASDAQ:VRML) released its earnings results on Thursday, August, 8th. The company reported ($0.06) earnings per share for the quarter. The business earned $1.14 million during the quarter. Vermillion had a negative net margin of 307.31% and a negative return on equity of 155.25%.
View Vermillion's earnings history

Who are some of Vermillion's key competitors?

What other stocks do shareholders of Vermillion own?

Who are Vermillion's key executives?

Vermillion's management team includes the following people:
  • Ms. Valerie Barber Palmieri, CEO, Pres & Director (Age 58)
  • Mr. Robert Harry Beechey CPA, Chief Financial Officer (Age 56)
  • Mr. Chris Goulart, Sr. VP of Commercial Operations

What is Vermillion's stock symbol?

Vermillion trades on the NASDAQ under the ticker symbol "VRML."

How do I buy shares of Vermillion?

Shares of VRML can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vermillion's stock price today?

One share of VRML stock can currently be purchased for approximately $3.09.

How big of a company is Vermillion?

Vermillion has a market capitalization of $300.41 million and generates $4.54 million in revenue each year. Vermillion employs 43 workers across the globe.

What is Vermillion's official website?

The official website for Vermillion is www.vermillion.com.

How can I contact Vermillion?

Vermillion's mailing address is 12117 BEE CAVES ROAD BUILDING THREE SUITE 100, AUSTIN TX, 78738. The company can be reached via phone at 512-519-0400 or via email at [email protected]

This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.